TY - JOUR
KW - Adult
KW - Amphetamine-Related Disorders/blood/drug therapy
KW - Animals
KW - Central Nervous System Stimulants/administration & dosage/adverse effects
KW - Cross-Over Studies
KW - Female
KW - Humans
KW - Inflammation Mediators/antagonists & inhibitors/blood
KW - Infusions, Intravenous
KW - Male
KW - Methamphetamine/administration & dosage/adverse effects
KW - Middle Aged
KW - Phosphodiesterase Inhibitors/pharmacology/therapeutic use
KW - Pyridines/pharmacology/therapeutic use
KW - Anti-inflammatory
KW - Cytokine
KW - Ibudilast
KW - Inflammation
KW - Methamphetamine
KW - Phosphodiesterase inhibitor
AU - M. J. Li
AU - M. S. Briones
AU - K. G. Heinzerling
AU - M. M. Kalmin
AU - S. J. Shoptaw
A1 - 
AD - Center for Behavioral and Addiction Medicine, Department of Family Medicine, University of California, Los Angeles, United States; Division of Infectious Diseases, University of California, Los Angeles, United States. Electronic address: mjli@mednet.ucla.edu.; Center for Behavioral and Addiction Medicine, Department of Family Medicine, University of California, Los Angeles, United States.; Center for Behavioral and Addiction Medicine, Department of Family Medicine, University of California, Los Angeles, United States.; Center for Behavioral and Addiction Medicine, Department of Family Medicine, University of California, Los Angeles, United States.; Center for Behavioral and Addiction Medicine, Department of Family Medicine, University of California, Los Angeles, United States.
BT - Drug and alcohol dependence
C5 - Opioids & Substance Use
DO - 10.1016/j.drugalcdep.2019.107776
JF - Drug and alcohol dependence
LA - eng
M1 - Journal Article
PB - Elsevier B.V
PY - 2020
SN - 1879-0046; 0376-8716; 0376-8716
SP - 107776
T1 - Ibudilast attenuates peripheral inflammatory effects of methamphetamine in patients with methamphetamine use disorder
T2 - Drug and alcohol dependence
TI - Ibudilast attenuates peripheral inflammatory effects of methamphetamine in patients with methamphetamine use disorder
U1 - Opioids & Substance Use
U2 - 31812878
U3 - 10.1016/j.drugalcdep.2019.107776
VL - 206
VO - 1879-0046; 0376-8716; 0376-8716
Y1 - 2020
Y2 - Jan 1
ER -